CFO of Antigenics Inc. (AGEN, Financial) Shalini Sharp sells 2,000 shares of AGEN on 09/14/2010 at an average price of $0.91 a share.
Antigenics Inc. has a market cap of $91.9 million; its shares were traded at around $0.93 with and P/S ratio of 27.6.
Antigenics Inc. has a market cap of $91.9 million; its shares were traded at around $0.93 with and P/S ratio of 27.6.
CFO Recent Trades:
- Sell: CFO Shalini Sharp sold 1,520 shares of AGEN stock on 07/27/2010 at the average price of 0.93. Shalini Sharp owns at least 241,098 shares after this. The price of the stock has decreased by 0% since.
- Sell: CFO Shalini Sharp sold 1,950 shares of AGEN stock on 04/27/2010 at the average price of 1.16. Shalini Sharp owns at least 238,868 shares after this. The price of the stock has decreased by 19.83% since.
Directors and Officers Recent Trades:
- Buy: Director Timothy Wright bought 10,000 shares of AGEN stock on 05/18/2010 at the average price of 1.34. Timothy Wright owns at least 10,000 shares after this. The price of the stock has decreased by 30.6% since.
- Sell: VP, Clin, Reg & Quality Kerry Wentworth sold 4,165 shares of AGEN stock on 07/26/2010 at the average price of 0.8. Kerry Wentworth owns at least 140,541 shares after this. The price of the stock has increased by 16.25% since.
- Sell: VP, Finance Christine M Klaskin sold 2,500 shares of AGEN stock on 07/26/2010 at the average price of 0.8. Christine M Klaskin owns at least 69,683 shares after this. The price of the stock has increased by 16.25% since.
- Sell: VP, Clin, Reg & Quality Kerry Wentworth sold 4,165 shares of AGEN stock on 04/26/2010 at the average price of 1.21. Kerry Wentworth owns at least 140,539 shares after this. The price of the stock has decreased by 23.14% since.
- Sell: VP, Finance Christine M Klaskin sold 2,500 shares of AGEN stock on 04/26/2010 at the average price of 1.21. Christine M Klaskin owns at least 69,683 shares after this. The price of the stock has decreased by 23.14% since.
